Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $4.88 to $5.63
• 50-Day Range: $2.90 to $5.57
• 52-Week Range: $2.34 to $8.79
• Volume: 215,675 shs
• Average Volume: 107,044 shs
• Market Capitalization: $200.85 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

Anteris Technologies Global Stock Analysis - MarketRank™

Anteris Technologies Global scored higher than 34% of companies evaluated by MarketBeat, and ranked 810th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Anteris Technologies Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Anteris Technologies Global has a consensus price target of $16.50, representing about 196.2% upside from its current price of $5.57.

Amount of Analyst Coverage

Anteris Technologies Global has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Anteris Technologies Global are expected to grow in the coming year, from ($2.66) to ($1.89) per share.

Price to Book Value per Share Ratio

Anteris Technologies Global has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.30% of the float of Anteris Technologies Global has been sold short.

Short Interest Ratio / Days to Cover

Anteris Technologies Global has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Anteris Technologies Global does not currently pay a dividend.

Dividend Growth

Anteris Technologies Global does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.30% of the float of Anteris Technologies Global has been sold short.

Short Interest Ratio / Days to Cover

Anteris Technologies Global has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.99

News Sentiment

Anteris Technologies Global has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Anteris Technologies Global this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Anteris Technologies Global insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.00% of the stock of Anteris Technologies Global is held by insiders.

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR stock has decreased by 0.2% and is now trading at $5.57.

How were Anteris Technologies Global's earnings last quarter?

Anteris Technologies Global Corp. (NASDAQ:AVR) announced its quarterly earnings data on Monday, August, 11th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.53) by $0.05. The business earned $0.62 million during the quarter, compared to analyst estimates of $0.58 million.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an initial public offering on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

Who are Anteris Technologies Global's major shareholders?

Top institutional shareholders of Anteris Technologies Global include L1 Capital Pty Ltd (7.80%), L1 Capital Pty Ltd (7.80%), Sio Capital Management LLC (5.10%) and Perceptive Advisors LLC (4.73%).

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/11/2025
• Today: 9/12/2025
• Next Earnings (Estimated): 11/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Anteris Technologies Global: $16.50
• High Price Target: $22.00
• Low Price Target: $9.00
• Potential Upside/Downside: +198.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.41
• Quick Ratio: 2.38

Sales & Book Value

• Annual Sales: $2.48 million
• Price / Sales: 80.44
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.74 per share
• Price / Book: 3.18

Miscellaneous

• Outstanding Shares: 36,062,000
• Free Float: 34,620,000
• Market Cap: $199.42 million
• Optionable: N/A
• Beta: N/A